Lisdexamfetamine Dimesylate Capsule shortage
Lisdexamfetamine Dimesylate Capsule is currently listed in shortage by the FDA. The FDA lists 90 affected products. The reported reason: Shortage of an active ingredient; Other; Delay in shipping of the drug. This page was last refreshed from FDA data on Oct 2, 2026.
Vyvanse (lisdexamfetamine) capsules have been in shortage for over a year, with supply problems tied to ingredient shortages and shipping delays. All strengths still have at least some supply, and makers not reporting a shortage — including Sandoz and Camber — list the 10 mg, 20 mg, 30 mg, and 40 mg strengths.
Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Lisdexamfetamine Dimesylate Capsule. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Oct 1, 2026Currently in shortage90 of 90 products affected.
-
Sep 18, 2026FDA refreshed this shortage record13 products updated.
-
Sep 17, 2026FDA refreshed this shortage record14 products updated.
-
Sep 16, 2026FDA refreshed this shortage record14 products updated.
-
Sep 15, 2026FDA refreshed this shortage record7 products updated.
-
Aug 20, 2026FDA refreshed this shortage record7 products updated.
-
Jun 29, 2026FDA refreshed this shortage record7 products updated.
-
Jun 24, 2026FDA refreshed this shortage record7 products updated.
-
Jun 17, 2026FDA refreshed this shortage record6 products updated.
-
May 12, 2026FDA refreshed this shortage record1 product updated.
-
Jan 11, 2024More presentations reported1 more product added to the shortage.
-
Nov 1, 2023More presentations reported7 more products added to the shortage.
-
Sep 20, 2023More presentations reported1 more product added to the shortage.
-
Jul 14, 2023First reported to the FDA81 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Alvogen 📞 844-842-8672 and email: [email protected] 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01) | — | Available | — | — |
Manufacturer: Amneal Pharmaceuticals 📞 866-525-7270 6 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09) | — | Available | — | — |
Manufacturer: Apotex Corp. 📞 800-706-5575 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1) | — | Unavailable | Estimated recovery: 9/25/26 | Delay in shipping of the drug |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1) | — | Available | — | — |
Manufacturer: Elite Laboratories, Inc. 📞 888-852-6657 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
Manufacturer: Hikma Pharmaceuticals USA, Inc. 📞 800-631-2174 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25) | — | Limited Availability | Available on allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25) | — | Limited Availability | Available on allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25) | — | Limited Availability | Available on allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25) | — | Limited Availability | Available on allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25) | — | Limited Availability | Available on allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25) | — | Limited Availability | Available on allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25) | — | Limited Availability | Available on allocation | Shortage of an active ingredient |
Manufacturer: Lannett Company, Inc. 📞 844-834-0530 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37) | — | Available | — | — |
Manufacturer: Mylan Pharmaceuticals Inc., a Viatris Company 📞 800-796-9526 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77) | — | Available | — | — |
Manufacturer: Rhodes Pharmaceuticals L.P. 📞 888-827-0616 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01) | — | Limited Availability | Estimated recovery: TBD | Shortage of an active ingredient |
Manufacturer: Solco Healthcare US, LLC 📞 866-931-9829 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10) | — | Limited Availability | On allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10) | — | Limited Availability | On allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10) | — | Limited Availability | On allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10) | — | Limited Availability | On allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10) | — | Limited Availability | On allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10) | — | Limited Availability | On allocation | Shortage of an active ingredient |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10) | — | Limited Availability | On allocation | Shortage of an active ingredient |
Manufacturer: SpecGx LLC 📞 800-325-8888 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01) | — | Available | — | — |
Manufacturer: Sun Pharmaceutical Industries, Inc. 📞 800-818-4555 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88) | — | Limited Availability | Estimated Recovery: TBD | Other |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-047-88) | — | Limited Availability | Estimated Recovery: TBD | Other |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-047-88) | — | Limited Availability | Estimated Recovery: TBD | Other |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88) | — | Limited Availability | Estimated Recovery: TBD | Other |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88) | — | Limited Availability | Estimated Recovery: TBD | Other |
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88) | — | Limited Availability | Estimated Recovery: TBD | Other |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88) | — | Limited Availability | Estimated Recovery: TBD | Other |
Manufacturer: Takeda Pharmaceuticals USA Inc. 📞 877-TAKEDA-7 (1-877-825-3327) 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Vyvanse, Capsule, 10 mg (NDC 59417-101-10) | — | Available | — | — |
| Current | Vyvanse, Capsule, 30 mg (NDC 59417-103-10) | — | Available | — | — |
| Current | Vyvanse, Capsule, 50 mg (NDC 59417-105-10) | — | Available | — | — |
| Current | Vyvanse, Capsule, 40 mg (NDC 59417-104-10) | — | Available | — | — |
| Current | Vyvanse, Capsule, 70 mg (NDC 59417-107-10) | — | Available | — | — |
| Current | Vyvanse, Capsule, 60 mg (NDC 59417-106-10) | — | Available | — | — |
| Current | Vyvanse, Capsule, 20 mg (NDC 59417-102-10) | — | Available | — | — |
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 7 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| Current | Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01) | — | Available | — | — |
| Current | Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01) | — | Available | — | — |
These rows are manufacturer reports to the FDA for Lisdexamfetamine Dimesylate Capsule — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Lisdexamfetamine Dimesylate Capsule? options further down this page.
Why is Lisdexamfetamine Dimesylate Capsule in shortage?
The main reason several manufacturers of lisdexamfetamine dimesylate capsules are on the FDA shortage list is a shortage of the active ingredient itself — meaning there simply isn't enough of the raw material needed to make the medicine at normal levels. This affects all strengths (10 mg through 70 mg) from Hikma Pharmaceuticals, Solco Healthcare, and Rhodes Pharmaceuticals, and those companies are currently distributing what they have "on allocation," meaning supplies are being carefully rationed. Rhodes has noted that recovery timing for most of their affected strengths (10 mg, 20 mg, 30 mg, 40 mg, 50 mg, and 70 mg) is still to be determined, though their 60 mg capsules are currently available.
It's worth noting that the shortage picture varies by manufacturer. Mylan, Lannett, and SpecGx are currently reporting their full lines of lisdexamfetamine capsules across all strengths as available. The FDA shortage reasons listed also include "other" and "shipping delays" as contributing factors for this shortage overall, though no further specific details were shared publicly beyond the active ingredient supply issue.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Lisdexamfetamine Dimesylate Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Lisdexamfetamine Dimesylate Capsule?
Lisdexamfetamine dimesylate capsules are currently on the FDA shortage list, but the supply picture is steady. Every strength — 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg, and 70 mg — still has an available source right now. There is no strength that is completely without supply, so the dose you take should be findable.
This has been an ongoing situation for more than a year, and the reported reasons include a shortage of an active ingredient, shipping delays, and other manufacturing factors. The important part: all 13 manufacturers on this record are still reporting supply. Some makers list their capsules as "on allocation," which simply means they are releasing limited quantities at a time, and recovery timing is mostly listed as to-be-determined. This is a supply slowdown, not a stop.
Here is what I suggest:
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to order your strength; they can check wholesalers and other manufacturers, since several makers still show it as available.
- If your usual brand is short, the same medicine is also made by other companies (for example, Sandoz or Camber) — your pharmacy may be able to source one, though it may not be in local stock.
- If your exact strength cannot be found, ask your prescriber or pharmacist about options, such as a clinician-chosen alternative.
Manufacturer contact numbers are listed on this page for reference, though your pharmacy usually makes these calls. This is national, manufacturer-reported information and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
- This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Lisdexamfetamine Dimesylate Capsule?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Lisdexamfetamine Dimesylate Capsule is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 10 mg/1 | Capsule · Oral | Sandoz Inc | 00781-2299-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 20 mg/1 | Capsule · Oral | Sandoz Inc | 00781-2476-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 30 mg/1 | Capsule · Oral | Sandoz Inc | 00781-2477-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 40 mg/1 | Capsule · Oral | Sandoz Inc | 00781-2478-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 50 mg/1 | Capsule · Oral | Sandoz Inc | 00781-2479-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 60 mg/1 | Capsule · Oral | Sandoz Inc | 00781-2480-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 70 mg/1 | Capsule · Oral | Sandoz Inc | 00781-2481-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 10 mg/1 | Capsule · Oral | Camber Pharmaceuticals, Inc. | 31722-0350-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 20 mg/1 | Capsule · Oral | Camber Pharmaceuticals, Inc. | 31722-0351-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 30 mg/1 | Capsule · Oral | Camber Pharmaceuticals, Inc. | 31722-0352-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 40 mg/1 | Capsule · Oral | Camber Pharmaceuticals, Inc. | 31722-0353-01 |
| Lisdexamfetamine Dimesylate | LISDEXAMFETAMINE DIMESYLATE 50 mg/1 | Capsule · Oral | Camber Pharmaceuticals, Inc. | 31722-0354-01 |
Alternative dosage forms of Lisdexamfetamine Dimesylate
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Lisdexamfetamine Dimesylate 20 mg | Hikma | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Mylan | 90 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | SpecGx | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine dimesylate 20 mg | Teva | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Lannett | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine dimesylate 20 mg | Sandoz | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Camber | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Rhodes | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine dimesylate 20 mg | Solco | 100 capsules | $2.437 | AB | Availability likely |
| lisdexamfetamine dimesylate 20 mg | Alvogen | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Sun | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Apotex | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | American | 30 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Elite | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Amneal | 90 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 20 mg | Granules | 100 capsules | $2.437 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Hikma | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Mylan | 90 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | SpecGx | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine dimesylate 40 mg | Teva | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Lannett | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine dimesylate 40 mg | Sandoz | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Camber | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Rhodes | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine dimesylate 40 mg | Solco | 100 capsules | $2.601 | AB | Availability likely |
| lisdexamfetamine dimesylate 40 mg | Alvogen | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Sun | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Apotex | 100 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | American | 30 capsules | $2.601 | AB | Availability likely |
| Lisdexamfetamine Dimesylate 40 mg | Elite | 100 capsules | $2.601 | AB | Availability likely |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Lisdexamfetamine Dimesylate Capsule — that fall in the same broad treatment class (adrenergics, aromatic, non-catecholamine) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other psychiatry shortages
Lisdexamfetamine Dimesylate Capsule shortage FAQs
Is Lisdexamfetamine Dimesylate Capsule in shortage?
Why is Lisdexamfetamine Dimesylate Capsule in shortage?
Which products are affected?
When will Lisdexamfetamine Dimesylate Capsule be available again?
Can I still get Lisdexamfetamine Dimesylate somewhere?
What should I do if I take Lisdexamfetamine Dimesylate Capsule?
Still have a question about the Lisdexamfetamine Dimesylate Capsule shortage?
Ask a pharmacist about this shortage →View Lisdexamfetamine Dimesylate Capsule on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.